Charcot-Marie-Tooth neuropathy type 1A (CMT1A) is a demyelinating peripheral neuropathy characterised by distal muscle weakness and atrophy and sensory loss. It is usually slowly progressive and often associated with pes cavus foot deformity and bilateral foot drop. Affected individuals usually become symptomatic between age five and 25 years.
Private and public patients: $305.15 (bulk billed)
Non-Medicare patients: $510.40
Routine analysis: 2-3 weeks
Urgent: 8-10 days
EDTA blood: Adults/Children: 5 ml
Saliva (please contact laboratory for saliva kits)